We are live on ! Find out more
PAVM icon

PAVmed
PAVM

22 hedge funds and large institutions have $932K invested in PAVmed in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

10% more funds holding

Funds holding: 20 → 22 (+2)

0.04% more ownership

Funds ownership: 0.35% → 0.39% (+0.04%)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

54% less capital invested

Capital invested by funds: $2.03M → $932K (-$1.1M)

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
5
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$3K

Top Buyers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
+$125K
2
AA
Axiom Advisory
California
+$64.8K
3
TSS
Two Sigma Securities
New York
+$41.9K
4
VF
Virtu Financial
New York
+$25.1K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$17.1K

Top Sellers

Rank Fund Capital Flow
1
VFA
Valeo Financial Advisors
Indiana
-$39.1K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$8.58K
3
SSG
Summit Securities Group
New York
-$8K
4
Wells Fargo
Wells Fargo
California
-$5.38K
5
Simplex Trading
Simplex Trading
Illinois
-$648
Name Holding Trade Value Shares
Change 		Change in
Stake
First Manhattan
1
First Manhattan
New York
$408K +$125K +2,500 +18%
Vanguard Group
2
Vanguard Group
Pennsylvania
$241K -$8.58K -172 -2%
AA
3
Axiom Advisory
California
$70.7K +$64.8K +1,299 New
BlackRock
4
BlackRock
New York
$61.1K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$60K +$17.1K +342 +16%
TSS
6
Two Sigma Securities
New York
$20.6K +$41.9K +841 New
State Street
7
State Street
Massachusetts
$17K -$199 -4 -0.6%
VF
8
Virtu Financial
New York
$12K +$25.1K +503 New
Northern Trust
9
Northern Trust
Illinois
$9.54K -$100 -2 -0.5%
XF
10
XML Financial
Maryland
$8.21K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$7.91K +$12K +241 +294%
Morgan Stanley
12
Morgan Stanley
New York
$4.13K -$100 -2 -1%
Carson Wealth (CWM LLC)
13
Carson Wealth (CWM LLC)
Nebraska
$4K – – –
UBS Group
14
UBS Group
Switzerland
$3.91K +$7.98K +160 New
Wells Fargo
15
Wells Fargo
California
$3.18K -$5.38K -108 -45%
CIBC Private Wealth Group
16
CIBC Private Wealth Group
Georgia
$664 – – –
AF
17
Allworth Financial
California
$425 – – –
Osaic Holdings
18
Osaic Holdings
Arizona
$94 – – –
Bank of America
19
Bank of America
North Carolina
$65 +$150 +3 New
PA
20
Parallel Advisors
California
$64 +$150 +3 New
MRCM
21
M&R Capital Management
New Jersey
$55 – – –
JP Morgan Chase
22
JP Morgan Chase
New York
$30 – – –
NA
23
NewEdge Advisors
Louisiana
$6 – – –
TIM
24
Thompson Investment Management
Wisconsin
$3 – – –
SPIA
25
Steward Partners Investment Advisory
New York
$1 – – –
1
2

PAVM Hedge Fund Activity: Q2 2024 in Review

22 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2024, worth a combined $932K — down 54% from $2.03M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PAVM positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 5 trimmed.

The largest buyer was First Manhattan, adding an estimated $125K. The largest seller was Valeo Financial Advisors, exiting entirely with an estimated $39.1K sold.

  • 22 institutional investors held PAVmed (PAVM) as of Q2 2024, up from 20 in Q1 2024.
  • Funds reported $932K of PAVmed stock for Q2 2024, down 54% quarter-over-quarter.
  • 6 funds opened new PAVmed positions in Q2 2024 and 4 closed out, a net change of +2 holders.
  • The largest PAVmed buyer in Q2 2024 was First Manhattan, an estimated $125K added.
  • The largest PAVmed seller in Q2 2024 was Valeo Financial Advisors, an estimated $39.1K sold.

Based on aggregated 13F filings for Q2 2024.